Zydus Lifesciences’ Desidustat Receives Approval from China’s NMPA
Zydus Lifesciences has received approval from China’s National Medical Products Administration (NMPA) for Desidustat tablets, indicated for the treatment of […]
ZYDUS-LIFESCIENCES
Zydus Lifesciences Launches Denosumab Biosimilar Zyrifa in India
Zydus Lifesciences has launched a Denosumab biosimilar in India, expanding its oncology and biologics portfolio and strengthening access to bone-health […]
Zydus Secures First NMPA Approval in China for Venlafaxine Extended-Release Capsules
Indian origin pharmaceutical giant Zydus Lifesciences Limited has announced that it has received marketing authorisation from the National Medical Products […]
Zydus’ $280M Power Move: Acquires 86% Stake in French MedTech Firm Amplitude Surgical
India’s Zydus Lifesciences has announced a major strategic acquisition, acquiring an 85.6% stake in French medical devices manufacturer Amplitude Surgical […]
Zydus Lifesciences’ API Manufacturing Facility Cleared by USFDA for Prostate Cancer Drug Supply
In a significant development for the pharmaceutical industry, Zydus Lifesciences has received clearance from the US Food and Drug Administration […]
Zydus Lifesciences Launches Rexigo, a Game-Changer Oral Therapy for Advanced Prostate Cancer Treatment in India
Zydus Lifesciences, a prominent player in the global healthcare sector, has unveiled Rexigo, the first-ever oral once-a-day therapy designed for […]
